![Chapter 21. Pharmacokinetics of Single-Dose Administration | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary Chapter 21. Pharmacokinetics of Single-Dose Administration | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary](https://pharmacylibrary.com/cms/10.21019/9781582121260.ch21/asset/images/medium/rits7_c021f001.gif)
Chapter 21. Pharmacokinetics of Single-Dose Administration | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary
![Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde.11.19/asset/images/medium/figure4.gif)
Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery
![Frontiers | Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges Frontiers | Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges](https://www.frontiersin.org/files/Articles/543082/fphar-11-00997-HTML/image_m/fphar-11-00997-g003.jpg)
Frontiers | Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2 | PLOS ONE
![Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde.11.19/asset/images/medium/figure2.gif)
Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug development | Therapeutic Delivery
![Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS - Journal of Pharmaceutical Sciences Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/asset/96d1bd55-710c-444b-974a-9ab5ba9327ae/gr1.gif)
Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS - Journal of Pharmaceutical Sciences
![Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS. | Semantic Scholar Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e3cd3afbf605d497be13f84b0533de88649dd5d3/2-Figure1-1.png)
Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS. | Semantic Scholar
![Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. - Abstract - Europe PMC Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3152312/bin/nihms311456f6.jpg)